Termination of Growth Capital Facility

Summary by AI BETAClose X

NeoTerra Group PLC has announced the termination of its Growth Capital Facility, confirming that only the Initial Tranche Shares, totaling 12,000,000 Ordinary Shares issued at nominal value to Zeus, were transferred. The company states that no further Facility Shares were issued and that the return of the Initial Tranche Shares to its control will proceed according to the established mechanism within the facility agreement.

Disclaimer*

Neoterra Group PLC
04 September 2026
 

4 September 2026

 

 

NEOTERRA GROUP PLC

("NeoTerra" or the "Company")

 

Termination of Growth Capital Facility

 

NeoTerra (LSE: TERA) (OTCQB: ANRCF), the African critical minerals exploration and development company, announces that its Growth Capital Facility (the "Facility") referred to in its announcement of 6 May 2026 (the "Announcement"), has been terminated.

 

Pursuant to the Facility, the Company issued 12,000,000 Ordinary Shares to Zeus at nominal value representing only the Initial Tranche Shares. No further Facility Shares were issued to Zeus.

 

The return of the Initial Tranche Shares to the control of the Company will be dealt with in accordance with the mechanism established in the Facility agreement.

 

Capitalised terms in this announcement shall have the same meaning ascribed to them in the Announcement unless the context requires otherwise.

 

 

For further information, please visit the Company's website: https://neoterra-group.com

 

-ends-

 

To subscribe for RNS alerts, please visit: https://neoterra-group.com/announcements

 

  

NeoTerra Group Plc

Cédric Simonet, CEO              +44 (0) 7769 555 757 (Cedric.Simonet@neoterra-group.com)

Louise Adrian, CFO                 +44 (0) 7721 492 922 (Louise.Adrian@neoterra-group.com)

           

Strand Hanson (Financial Adviser)                                                      +44 (0) 20 7409 3494

Christopher Raggett

Imogen Ellis

 

Zeus Capital (Corporate Broker)                                                         +44 (0) 20 3829 5000

Simon Johnson

James Hornigold 

 

 

About NeoTerra Group Plc 

 

NeoTerra Group Plc (LSE:TERA)(OTCQB:ANRF) is a London Main Market-listed exploration and development company focused on unlocking the value of critical raw materials across Africa. The Company is pursuing a diversified strategy, targeting assets with potential for near-term monetisation alongside long-term growth.

 

The multi-commodity Monte Muambe Project in northwest Mozambique is a highly prospective tenement hosting rare earths, fluorspar, and gallium mineralisation. Published JORC mineral resource estimates include:

 

·    13.6Mt at 2.42% TREO

·    3.48Mt at 20.6% CaF2

·    11.73Mt at 54.7g/t Ga2O3

 

The project is held under a 25-year mining licence and has received US Government support in the form of a US$ 1.875 million grant from USTDA to advance the rare earths component through the prefeasibility stage.

 

NeoTerra's diversified portfolio also includes the Sesana Copper-Silver Project in Botswana, strategically located just 25 km from MMG's Khoemacau Zone 5 copper-silver mine.

 

With a unique combination of critical raw materials projects, NeoTerra is well positioned to contribute to the global supply of strategically important commodities essential for clean energy, high technology, defence and industrial applications.

 

The Company and the Board remain actively focused on identifying and evaluating additional projects that align with our investment profile and strategic objectives, leveraging our extensive network and combined industry experience to uncover compelling opportunities that can drive long-term growth.

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
UK 100

Latest directors dealings